Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
Human cardiomyocytes (CMs) have potential for use in therapeutic cell therapy and high-throughput drug screening. Because of the inability to expand adult CMs, their large-scale production from human pluripotent stem cells (hPSC) has been suggested. Significant improvements have been made in underst...
Main Authors: | Bianca Williams, Wiebke Löbel, Ferdous Finklea, Caroline Halloin, Katharina Ritzenhoff, Felix Manstein, Samira Mohammadi, Mohammadjafar Hashemi, Robert Zweigerdt, Elizabeth Lipke, Selen Cremaschi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2020.00851/full |
Similar Items
-
Directed Differentiation of Zebrafish Pluripotent Embryonic Cells to Functional Cardiomyocytes
by: Yao Xiao, et al.
Published: (2016-09-01) -
Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells
by: Xiaoqian Zhang, et al.
Published: (2017-04-01) -
Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles
by: Yamoah MA, et al.
Published: (2018-10-01) -
Toward the realization of cardiac regenerative medicine using pluripotent stem cells
by: Yoshikazu Kishino, et al.
Published: (2020-01-01) -
Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes
by: Wei Lei, et al.
Published: (2018-03-01)